Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youlan Rao

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Lung|November 19, 2020
Follow-Up Functional Class and 6-Minute Walk Distance Identify Long-Term Survival in Pulmonary Arterial HypertensionGustavo A Heresi, Youlan Rao
American Journal of Respiratory and Critical Care Medicine|June 16, 2016
Novel Analysis of the Oral Treprostinil Combination Therapy Trial DataR James White, Youlan Rao
Heart, Lung & Circulation|April 13, 2017
Impact of Pulmonary Capillary Wedge Pressure on Long-Term Mortality in Patients With Pulmonary Arterial Hypertension Treated With Parenteral TrepostinilJignesh K Patel, Youlan Rao, Paul Strachan
Frontiers in Cardiovascular Medicine|May 20, 2020
Reduced RVSWI Is Associated With Increased Mortality in Connective Tissue Disease Associated Pulmonary Arterial HypertensionKatharine R Clapham, Kristin B Highland, Youlan Rao, et al.
Respiratory Medicine|December 24, 2024
The minimally important difference in the six-minute walk test predicts clinical worsening in pulmonary arterial hypertensionArsal Tharwani, Omar Minai, Youlan Rao, et al.
Cardiovascular Therapeutics|June 24, 2017
Impact on survival of warfarin in patients with pulmonary arterial hypertension receiving subcutaneous treprostinilMona Ascha, Xuan Zhou, Youlan Rao, et al.
Pulmonary Circulation|January 17, 2017
Relevance of angiopoietin-2 and soluble P-selectin levels in patients with pulmonary arterial hypertension receiving combination therapy with oral treprostinil: a FREEDOM-C2 biomarker substudyManuel J Richter, Ralph Schermuly, Werner Seeger, et al.
Pulmonary Circulation|July 24, 2018
Association between cytokines and functional, hemodynamic parameters, and clinical outcomes in pulmonary arterial hypertensionAditya A Joshi, Ryan Davey, Youlan Rao, et al.
Pulmonary Circulation|December 24, 2015
Sex and menopause differences in response to tadalafil: 6-minute walk distance and time to clinical worseningJennifer Rusiecki, Youlan Rao, Jody Cleveland, et al.
Pulmonary Circulation|June 10, 2017
Novel approach to classifying patients with pulmonary arterial hypertension using cluster analysisKishan S Parikh, Youlan Rao, Tariq Ahmad, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Lung|November 19, 2020
Follow-Up Functional Class and 6-Minute Walk Distance Identify Long-Term Survival in Pulmonary Arterial HypertensionGustavo A Heresi, Youlan Rao
American Journal of Respiratory and Critical Care Medicine|June 16, 2016
Novel Analysis of the Oral Treprostinil Combination Therapy Trial DataR James White, Youlan Rao
Heart, Lung & Circulation|April 13, 2017
Impact of Pulmonary Capillary Wedge Pressure on Long-Term Mortality in Patients With Pulmonary Arterial Hypertension Treated With Parenteral TrepostinilJignesh K Patel, Youlan Rao, Paul Strachan
Frontiers in Cardiovascular Medicine|May 20, 2020
Reduced RVSWI Is Associated With Increased Mortality in Connective Tissue Disease Associated Pulmonary Arterial HypertensionKatharine R Clapham, Kristin B Highland, Youlan Rao, et al.
Respiratory Medicine|December 24, 2024
The minimally important difference in the six-minute walk test predicts clinical worsening in pulmonary arterial hypertensionArsal Tharwani, Omar Minai, Youlan Rao, et al.
Cardiovascular Therapeutics|June 24, 2017
Impact on survival of warfarin in patients with pulmonary arterial hypertension receiving subcutaneous treprostinilMona Ascha, Xuan Zhou, Youlan Rao, et al.
Pulmonary Circulation|January 17, 2017
Relevance of angiopoietin-2 and soluble P-selectin levels in patients with pulmonary arterial hypertension receiving combination therapy with oral treprostinil: a FREEDOM-C2 biomarker substudyManuel J Richter, Ralph Schermuly, Werner Seeger, et al.
Pulmonary Circulation|July 24, 2018
Association between cytokines and functional, hemodynamic parameters, and clinical outcomes in pulmonary arterial hypertensionAditya A Joshi, Ryan Davey, Youlan Rao, et al.
Pulmonary Circulation|December 24, 2015
Sex and menopause differences in response to tadalafil: 6-minute walk distance and time to clinical worseningJennifer Rusiecki, Youlan Rao, Jody Cleveland, et al.
Pulmonary Circulation|June 10, 2017
Novel approach to classifying patients with pulmonary arterial hypertension using cluster analysisKishan S Parikh, Youlan Rao, Tariq Ahmad, et al.
Pageof 3